Ventricular Tachycardia (VT) Ablation Versus Enhanced Drug Therapy (VANISH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Capital District Health Authority, Canada
Sponsor:
Collaborators:
St. Jude Medical
Biosense Webster, Inc.
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
John Sapp, Capital District Health Authority, Canada
ClinicalTrials.gov Identifier:
NCT00905853
First received: May 20, 2009
Last updated: March 31, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)